Inicio › Cáncer de pulmón de células no pequeñas › California › Mountain View
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Mountain View, CA
21 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Mountain View y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
ReclutandoFase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · A 5 mi de distancia
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · A 5 mi de distancia
- Stanford Cancer Institute Palo Alto, Palo Alto · A 5 mi de distancia
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
ReclutandoFase 3
- Stanford University, Stanford · A 5 mi de distancia
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
ReclutandoFase 2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Stanford University, Palo Alto · A 5 mi de distancia
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
ReclutandoFase 2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
- Stanford Hospital and Clinics, Stanford · A 5 mi de distancia
- Stanford Hospital Investigational Drug Services, Stanford · A 5 mi de distancia
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
ReclutandoFase 3
- Stanford Cancer Center, Palo Alto · A 5 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
ReclutandoFase 1/2
- Stanford University Medical Center - Neurology, Stanford · A 5 mi de distancia
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · A 5 mi de distancia
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
ReclutandoFase 1/2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
ReclutandoFase 1/2
- Stanford University Medical Center, Stanford · A 5 mi de distancia
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
ReclutandoFase 1
- Stanford University Medical Center, Palo Alto · A 5 mi de distancia
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
ReclutandoFase 1
- Stanford University, Palo Alto · A 5 mi de distancia
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ReclutandoFase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · A 5 mi de distancia
A Study of LY4175408 in Participants With Advanced Cancer
ReclutandoFase 1
- Stanford Medicine Cancer Center, Stanford · A 5 mi de distancia
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Stanford University, Stanford · A 5 mi de distancia
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
ReclutandoFase 1/2
- Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
Engagement of Veterans With Lung Cancer
Reclutando
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · A 5 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Stanford · A 5 mi de distancia
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
ReclutandoFase 1
- Stanford University, Stanford · A 5 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Mountain View
- Cáncer (todos los tipos)40 estudios
- Cáncer de seno26 estudios
- Cáncer metastásico25 estudios
- Leucemia mielógena aguda19 estudios
- Cáncer de ovario19 estudios
- Trastorno del espectro autista17 estudios
- Cáncer de pulmón17 estudios
- Cáncer de próstata15 estudios
- Fallo cardíaco15 estudios
- Autismo13 estudios
- Leucemia linfoblástica aguda13 estudios
- Cáncer del colon y del recto13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.